World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615001247561
Date of registration: 13/11/2015
Prospective Registration: Yes
Primary sponsor: Curtin University
Public title: An evaluation of cardiac rehabilitation and secondary prevention uptake and utilisation for acute coronary syndrome patients.
Scientific title: Evaluation of quality of care in cardiac rehabilitation for acute coronary syndrome patients.
Date of first enrolment: 01/12/2015
Target sample size: 1000
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12615001247561.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial;  
Phase: 
Countries of recruitment
Australia China
Contacts
Name: A/Prof Andrew Maiorana   
Address:  Fiona Stanley Hospital Advanced Heart Failure and Cardiac Transplant Service Clinic. 11 Robin Warren Drive Murdoch, WA 6150 Australia
Telephone: +61 8 9266 9225
Email: Andrew.Maiorana@health.wa.gov.au
Affiliation: 
Name: A/Prof Andrew Maiorana   
Address:  Fiona Stanley Hospital Advanced Heart Failure and Cardiac Transplant Service Clinic. 11 Robin Warren Drive Murdoch, WA 6150. Australia
Telephone: +61 8 9266 9225
Email: Andrew.Maiorana@health.wa.gov.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Clinical Audit: All patients admitted at FSH with a diagnosis of ACS during the two cycles of audit (for the six month periods beginning 1 January 2016 and 2017 respectively) will be included in the Audit.

Patient Survey: Current patients admitted to FSH with an ACS during the strudy period.

Staff Survey: Currently employed staff who working at cardiology department of FSH as a care giver providing cardiology service to both outpatient and inpatient are eligible to participate the study.

Patient Focus Groups & Staff Interviews: One in four of the patients who returned surveys will be randomly selected and contacted by a phone call from the research team to take part in focus group discussions. Similarly, staff will be randomly selected to take part in face-to-face interviews subsequent to the surveys since it is unlikely to be possible to arrange a group discussion for medical/health staff in a busy clinical setting.

Exclusion criteria: Hospitality mortality data will be reviewed and invitation letters or phone calls for participating the survey and focus group discussion will not be sent to the addresses of deceased patients.

Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Acute Coronary Syndrome;
Acute Coronary Syndrome
Cardiovascular - Coronary heart disease
Intervention(s)
1. Based on data collected from the first cycle of clinical audit, as well as surveys and group discussions, quality improvement initiatives will be developed and implanted. This may include redesigning the cardiac rehabilitation referral system, improving patient education program, developing advocacy programs for cardiac rehabilitation and secondary prevention among patients and staff, developing alternative models of cardiac rehabilitation and secondary prevention etc.
2. After the first cycle of clinical audit, current ACS patients will be asked to complete a survey (and some to attend focus groups) and Cardiology Ward staff will be invited to complete a survey (and some attend individual interviews with the researchers).
3. Quality improvement initiatives will be developed and implanted between the two audit cycles within a period of 6 months. The effectiveness of the initiatives will be evaluated through the second cycle of clinical audit.
Primary Outcome(s)
Change in the number of admitted ACS patients receiving guideline advocated secondary prevention therapies. This the outcome will be assessed through the second cycle of clinical audit by review medical records with indicators including utilization of evidence based medecine, referral for cardiac rehabilitation program, risk factor monitoring and control etc. [3 months after performance improvement strategies developed and implemented.]
Change in the number of admitted ACS patients receiving core components of cardiac rehabilitation. This the outcome will be assessed through the second cycle of clinical audit by review of medical records, FSH electronic referral system with indicators including referral rates, participation and completion rates of cardiac rehabilitation etc. [3 months after performance improvement strategies developed and implemented.]
Secondary Outcome(s)
Cardiac rehabilitation refferal rates will be monitored by using the electronic cardiac rehabilitation referral system after the implementation of quality improvement initiatives.. [6 months after performance improvement strategies developed and implemented.]
Secondary ID(s)
NIL
Source(s) of Monetary Support
Curtin University PhD student research funding
Secondary Sponsor(s)
Ethics review
Status: Not approved
Approval date:
Contact:
Royal Perth Hospital HREC
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history